SynapCell
About:
SynapCell is a preclinical contract research organization, providing solutions for the therapeutic potential of CNS candidates in epilepsy.
Website: http://www.synapcell.fr/
Twitter/X: SynapC
Top Investors: Grenoble Angels, Rhone-Alpes Creation, Expansinvest, VIADUC 8
Description:
SynapCell is a French simplified joint-stock company founded in April 2005 and located at Grenoble, France. The mission of SynapCell is to bring added-value to CNS drug development by creating solutions for preclinical evaluation of CNS therapeutics and providing consulting, pre-designed and customized programs to experts in the biopharmaceutical industry.
$4.43M
$1M to $10M
Grenoble, Rhone-Alpes, France
2005-04-01
Corinne Roucard, Yann Roche
11-50
2009-03-06
Private
© 2025 bioDAO.ai